(Q44668514)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14637101%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

The effects of chronic L-DOPA therapy on pharmacodynamic parameters in a rat model of motor response fluctuations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14637101%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14637101%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

Eun Ah Lee

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14637101%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Won Yong Lee

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14637101%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Un Jung Kang

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14637101%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

language of work or name

English

0 references

publication date

1 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14637101%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

published in

Experimental Neurology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14637101%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

184

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14637101%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14637101%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

304-312

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14637101%20AND%20SRC:MED&resulttype=core&format=json

Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: studies on medial forebrain bundle and striatal lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

Aromatic Amino Acids and Modification of Parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

The effects of chronic continuous versus intermittent levodopa treatments on striatal and extrastriatal D1 and D2 dopamine receptors and dopamine uptake sites in the 6-hydroxydopamine lesioned rat--an autoradiographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

Differential effect of chronic dopaminergic treatment on dopamine D1 and D2 receptors in the monkey brain in MPTP-induced parkinsonism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

Continuous and intermittent levodopa differentially affect basal ganglia function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

Reversal of motor impairments in parkinsonian rats by continuous intrastriatal delivery of L-dopa using rAAV-mediated gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

Long-term sensitization of apomorphine-induced rotation behavior in rats with dopamine deafferentation or excitotoxin lesions of the striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

The effect of stage of Parkinson's disease at the onset of levodopa therapy on development of motor complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase enhance dopamine delivery after L-3, 4-dihydroxyphenylalanine administration in Parkinsonian rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

Success and problems of long-term levodopa therapy in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

Time and dose dependence of the 'priming' of the expression of dopamine receptor supersensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

Sensitization of rotation behavior in rats with unilateral 6-hydroxydopamine or kainic acid-induced striatal lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

Motor fluctuations and dyskinesia in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

Pharmacodynamics of levodopa in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

Long-duration response to levodopa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

The response to levodopa in Parkinson's disease: imposing pharmacological law and order

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

Short- and long-duration responses to levodopa during the first year of levodopa therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

Evolution of the response to levodopa during the first 4 years of therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

Motor fluctuations in levodopa treated parkinsonian rats: relation to lesion extent and treatment duration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

Differential effect of repeated treatment with L-dopa on dopamine-D1 or -D2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

Turning behaviour in animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

Levodopa peak response time reflects severity of dopamine neuron loss in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

Loss of long-duration response to levodopa over time in PD: implications for wearing-off

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900159-6

10.1016/S0014-4886(03)00159-6

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14637101%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference